Indications
The prevention of premature luteinising-hormone surges in women undergoing controlled ovarian hyperstimulation for assisted reproduction techniques. In clinical studies, Orgalutran was used with recombinant human follicle-stimulating hormone or corifollitropin alfa, the sustained follicle stimulant.
Composition
- Active substance
- ganirelix
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Orgalutran
- Active substance
- ganirelix
- ATC code
- H01CC01
- Therapeutic area
- Reproductive Techniques, Assisted, Ovulation Induction, Infertility, Female
- Marketing authorisation holder